A universally applicable 68Ga-labeling technique for proteins

Journal of Nuclear Medicine

Volumn 52, Issue 4, 2011, Pages 586-591

  Wängler, Carmen ^a,b   Wängler, Björn ^b   Lehner, Sebastian ^b   Elsner, Andreas ^c   Todica, Andrei ^b   Bartenstein, Peter ^b   Hacker, Marcus ^b   Schirrmacher, Ralf ^a  

^a MCGILL UNIVERSITY   (Canada)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c HERMES MEDICAL SOLUTIONS   (Sweden)

Author keywords

68Ga labeling; Annexin V; Kit; PE.T.; Proteins; Rat serum albumin

Indexed keywords

2,2' [7 [1 CARBOXY 4 (2 MERCAPTOETHYLAMINO) 4 OXOBUTYL] 1,4,7 TRIAZONANE 1,4 DIYL]DIACETIC ACID; CHELATING AGENT; GALLIUM 68; LIPOCORTIN 5 GA 68; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; ACTIN BINDING PROTEIN; CALCIUM BINDING PROTEIN; CALPONIN; DIAGNOSTIC AGENT; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; GALLIUM; LIPOCORTIN 5; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CHEMICAL LABELING; CHEMICAL REACTION; CONTROLLED STUDY; DIAGNOSTIC IMAGING; HEART INFARCTION; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN PURIFICATION; RADIOCHEMISTRY; ROOM TEMPERATURE; SYNTHESIS; ANIMAL; CARDIAC GATED IMAGING; CHEMISTRY; ISOTOPE LABELING; METHODOLOGY; PHYSIOLOGY; RAT; TISSUE DISTRIBUTION;

ANIMALS; ANNEXIN A5; APOPTOSIS; CALCIUM-BINDING PROTEINS; GALLIUM RADIOISOTOPES; GATED BLOOD-POOL IMAGING; INDICATORS AND REAGENTS; ISOTOPE LABELING; MICE; MICROFILAMENT PROTEINS; PROTEINS; RADIOPHARMACEUTICALS; RATS; TISSUE DISTRIBUTION;

EID: 79954613959     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.110.082198     Document Type: Article

References (25)

1. Willmann JK, van Bruggen N, Dinkelborg LM, Gambhir SS. Molecular imaging in drug development. Nat Rev Drug Discov. 2008;7:591-607. (Pubitemid 351927724)
2. Ametamey SM, Honer M, Schubiger PA. Molecular imaging with PET. Chem Rev. 2008;108:1501-1516. (Pubitemid 351796395)
3. 18F, 15O, and 13N radiolabels for positron emission tomography. Angew Chem Int Ed Engl. 2008;47:8998-9033.
4. Maecke HR, Hofmann M, Haberkorn U. 68Ga-labeled peptides in tumor imaging. J Nucl Med. 2005;46(suppl 1):172S-178S.
5. Fani M, Andre JP, Maecke HR. 68Ga-PET: A powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals. Contrast Media Mol Imaging. 2008;3:67-77.
6. Wadas TJ, Wong EH, Weisman GR, Anderson CJ. Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease. Chem Rev. 2010;110:2858-2902.
7. Velikyan I, Maecke H, Langstrom B. Convenient preparation of 68Ga-based PETradiopharmaceuticals at room temperature. Bioconjug Chem. 2008;19:569-573. (Pubitemid 351294931)
8. Jeong JM, Hong MK, Chang YS, et al. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4, 7-triazacyclononane- 1,4,7-triacetic acid and feasibility studies in mice. J Nucl Med.2008;49:830-836.
9. Eder M, Krivoshein AV, Backer M, Backer JM, Haberkorn U, Eisenhut M. ScVEGF-PEG-HBED-CC and scVEGF-PEG-NOTA conjugates: Comparison of easy-to-label recombinant proteins for [Ga-68]PET imaging of VEGF receptors in angiogenic vasculature. Nucl Med Biol. 2010;37:405-412.
10. Eder M, Wängler B, Knackmuss S, et al. Tetrafluorophenolate of HBED-CC: A versatile conjugation agent for Ga-68-labeled small recombinant antibodies. Eur J Nucl Med Mol Imaging. 2008;35:1878-1886.
11. Lee J, Garmestani K, Wu C, et al. In vitro and in vivo evaluation of structurestability relationship of 111In- and 67Ga-labeled antibody via 1B4M or C-NOTA chelates. Nucl Med Biol. 1997;24:225-230. (Pubitemid 27293466)
12. Mier W, Hoffend J, Kramer S, et al. Conjugation of DOTA using isolated phenolic active esters: The labeling and biodistribution of albumin as blood pool marker. Bioconjug Chem. 2005;16:237-240. (Pubitemid 40129699)
13. Govindan SV, Goldenberg DM, Elsamra SE, et al. Radionuclides linked to a CD74 antibody as therapeutic agents for B-cell lymphoma: Comparison of Auger electron emitters with beta-particle emitters. J Nucl Med. 2000;41: 2089-2097. (Pubitemid 32038701)
14. Ochakovskaya R, Osorio L, Goldenberg DM, Mattes MJ. Therapy of disseminated B-cell lymphoma xenografts in severe combined immunodeficient mice with an anti-CD74 antibody conjugated with 111indium, 67gallium, or 90yttrium. Clin Cancer Res. 2001;7:1505-1510. (Pubitemid 32708612)
15. Brechbiel MW, Gansow OA, Atcher RW, et al. Synthesis of 1-(p-isothiocyanatobenzyl) derivatives of DTPA and EDTA: Antibody labeling and tumor-imaging studies. Inorg Chem. 1986;25:2772-2781. (Pubitemid 17169742)
16. Nikula TK, Bocchia M, Curcio MJ, et al. Impact of the high tyrosine fraction in complementarity determining regions: Measured and predicted effects of radioiodination on IgG immunoreactivity. Mol Immunol. 1995;32:865-872.
17. Wängler C, Moldenhauer G, Eisenhut M, Haberkorn U, Mier W. Antibodydendrimer conjugates: The number, not the size of the dendrimers, determines the immunoreactivity. Bioconjug Chem. 2008;19:813-820. (Pubitemid 351614537)
18. McMurry TJ, Brechbiel M, Wu C, Gansow OA. Synthesis of 2-(p-thiocyanatobenzyl)- 1,4,7-triazacyclononane-1,4,7-triacetic acid: Application of the 4-methoxy- 2,3,6-trimethylbenzenesulfonamide protecting group in the synthesis of macrocyclic polyamines. Bioconjug Chem. 1993;4:236-245.
19. Chia S, Senatore F, Raffel OC, Lee H, Wackers FJ, Jang IK. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2008;1:415-423.
20. Ten Cate TJ, Van Hemel NM, Verzijlbergen JF. Myocardial perfusion defects in right ventricular apical pacing are caused by partial volume effects because of wall motion abnormalities: A new model to study gated myocardial SPECT with the pacemaker on and off. Nucl Med Commun. 2009;30:480-484.
21. Blankenberg FG, Tait J, Ohtsuki K, Strauss HW. Apoptosis: The importance of nuclear medicine. Nucl Med Commun. 2000;21:241-250.
22. Lahorte CM, Vanderheyden JL, Steinmetz N, Van de Wiele C, Dierckx RA, Slegers G. Apoptosis-detecting radioligands: Current state of the art and future perspectives. Eur J Nucl Med Mol Imaging. 2004;31:887-919. (Pubitemid 38765126)
23. Boersma HH, Kietselaer BL, Stolk LM, et al. Past, present, and future of annexin A5: From protein discovery to clinical applications. J Nucl Med. 2005;46:2035-2050. (Pubitemid 46657451)
24. Laufer EM, Reutelingsperger CP, Narula J, Hofstra L. Annexin A5: An imaging biomarker of cardiovascular risk. Basic Res Cardiol. 2008;103:95-104. (Pubitemid 351356752)
25. Gavrieli Y, Sherman Y, Ben-Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992;119: